Thought Leadership
Blog | October 20, 2016
Biogen Dodges IPR Bullet on Key Tysabri® Patents
Fish & Richardson
Read more
Blog | October 17, 2016
USPTO Publishes Amendments to Trademark Rules of Practice
Fish & Richardson
Read more
Blog | October 13, 2016
Federal Circuit Affirms the Dismissal of a Complaint That Insufficiently Pleaded Joint Infringement
Fish & Richardson
Read more
Blog | October 07, 2016
Amgen Appeals Loss of Neulasta® and Neupogen® Litigation
Fish & Richardson
Read more
Blog | October 06, 2016
EDTX denies exclusion of settlement license and "real estate" apportionment
Fish & Richardson
Read more
Blog | September 30, 2016
Court Orders Entry of Final Judgment of Invalidity in Ongoing Janssen v. Celltrion BPCIA Dispute
Fish & Richardson
Read more
Blog | September 16, 2016
My Intellectual Property Licensor is Bankrupt — Now What?
Fish & Richardson
Read more
Article | September 14, 2016
Read more
An End-Run Around Myriad And 'Product Of Nature' Problem
Law360
Blog | September 06, 2016
D.Ariz excludes expert for not apportioning the rate, but OKs entire product as base
Fish & Richardson
Read more
Blog | August 27, 2016
Medical Diagnostic Tests — Are They Patentable? Don't Count On It.
Fish & Richardson
Read more